Given that OPN is increased in liver (Lima‐Cabello et al., 2010) and serum of NAFLD patients (Nunez‐Garcia et al., 2017), OPN levels were also measured in a cohort of NAFLD patients (n = 89) (Figure 1b) (Table 1). This evidence concerns the gene SPP1 and metabolic dysfunction-associated steatotic liver disease.